Cullinan Oncology LLC (CGEM) support and resistance · $830.3M cap
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
This page maps Cullinan Oncology LLC (CGEM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
CGEM currently screens at market cap $830.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CGEM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CGEM quote page for the session range and the stock page for the full model.
Not investment advice.